Blog | Insights on drug delivery & innovation

For the record: How past experience enables future success

Jakob Lange and Shawn James discuss the value of the experience hidden behind metrics such as completed projects and commercialized devices – the wealth of accumulated process knowledge that enables a company to bring hard-learned lessons forwards.

Beyond drug delivery: Three lenses for selecting an on-body platform

Reto Jost, Nadine Kaufmann and Shawn James discuss three complementary decision lenses and explain how they offer a practical framework for evaluating early platform decisions that can shape outcomes across the entire product lifecycle of wearable …

Post-conference summary: Combination Products Summit 2026

The 8th Annual Combination Products Summit, organized by PharmaEd on May 27–28, 2026, brought together stakeholders from across the combination product ecosystem — pharmaceutical companies, device manufacturers, regulatory consultancies, and …

Interview: Enhancing Clinical Trials with CliniPilot and Clear to Clinic Programme

In this exclusive interview, Dr Carolina Canapè and Roger Lüscher talk with ONdrugDelivery’s Guy Furness about the application of connectivity in decentralised trials, and how Ypsomed’s CliniPilot and the company’s range of clinic-ready autoinjectors …

Closing the loop: Designing the future of sustainable drug delivery devices

As pharma moves toward net zero, device sustainability is under the spotlight. In our latest blog, Thuysi Dao outlines a two-pronged approach that combines sustainable device design with take-back and recycling possibilities – showcased through the …

Divergent design philosophies in the wearable injector segment

Wearable injectors come in many shapes and concepts. Our latest blog explores this diversity, and shows how YpsoDose stands out with consistent injection and minimal residual volume in large-volume self-injection.

Patient-centricity at the heart of innovation

Discover the patient-driven design behind YpsoDose, our wearable patch injector for large-volume biologics. Learn how human factors shaped its intuitive, comfortable, and reliable use—simplifying self-injection for patients at home.

Optimizing high-dose delivery

Subcutaneous injection or high-dose formulations requires optimized solutions. This joint article by Ypsomed and BD explores how YpsoMate 2.25 and BD Neopak™ syringes perform across a range of viscosities.

Sustainable GLP-1 drug delivery

GLP-1 therapies are entering a high-growth phase, driving demand for scalable, sustainable delivery solutions. As formulations evolve, device usability, and environmental impact becomes a key industry challenge.

Welcome to the Ypsomed Blog